• Record: found
  • Abstract: found
  • Article: not found

Development and validation of a HPLC-MS-MS method for quantification of metronidazole in human plasma.

Journal of chromatographic science

methods, Biological Availability, Chromatography, High Pressure Liquid, Humans, Metronidazole, blood, pharmacokinetics, Tandem Mass Spectrometry

Read this article at

      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


      The objective of this study was to describe an analytical validation of a simple, rapid, sensitive, and selective liquid chromatography (LC)-tandem mass spectrometry (MS-MS) method for quantification of metronidazole in human plasma samples from bioavailability studies. The plasma samples were pre-treated by liquid-liquid extraction (LLE) with ethyl acetate. Metronidazole and the internal standard (IS) zidovudine were analyzed by combined reversed-phase LC-MS-MS with positive ion electrospray ionization. Multiple reactions monitoring (MRM) of the transitions were used as follows: m/z 171.97 > 127.97 for metronidazole and m/z 268.08 > 126.96 for IS. The main chromatography conditions used were a Varian C(18) Microssorb model (150 mm x 4.6 mm i.d., 5 microm particle size) column, and the mobile phase was composed of acetonitrile and 10 mM ammonium acetate (80:20, v/v) and 0.1% formic acid. Flow rate used was 1.0 mL/min with splitter. The method was linear over a concentration range of 0.05-8.00 microg/mL. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. The developed method was validated and successfully applied to a pilot bioequivalence study of metronidazole in healthy volunteers.

      Related collections

      Author and article information



      Comment on this article